Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS- CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant National Healthcare Safety Network, March 1-August 1, 2021

被引：1

作者：

Nanduri, Srinivas ^{[1
]}

Pilishvili, Tamara ^{[1
]}

Derado, Gordana ^{[1
]}

Soe, Minn Minn ^{[1
]}

Dollard, Philip ^{[1
]}

Wu, Hsiu ^{[1
]}

Li, Qunna ^{[1
]}

Bagchi, Suparna ^{[1
]}

Dubendris, Heather ^{[1
,2
]}

Link-Gelles, Ruth ^{[1
]}

Jernigan, John A. ^{[1
]}

Budnitz, Daniel ^{[1
]}

Bell, Jeneita ^{[1
]}

Benin, Andrea ^{[1
]}

Shang, Nong ^{[1
]}

Edwards, Jonathan R. ^{[1
]}

Verani, Jennifer R. ^{[1
]}

Schrag, Stephanie J. ^{[1
]}

机构：

[1] CDC, COVID 19 Response Team, Atlanta, GA 30333 USA

[2] Lantana Consulting Grp, East Thetford, VT USA

来源：

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT | 2021年 / 70卷 / 34期

关键词：

UNITED-STATES; COVID-19;

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

What is already known about this topic? Early observational studies among nursing home residents showed mRNA vaccines to be 53% to 92% effective against SARS-CoV-2 infection. What is added by this report? Two doses of mRNA vaccines were 74.7% effective against infection among nursing home residents early in the vaccination program (March-May 2021). During June-July 2021, when B.1.617.2 (Delta) variant circulation predominated, effectiveness declined significantly to 53.1%. What are the implications for public health practice? Multicomponent COVID-19 prevention strategies, including vaccination of nursing home staff members, residents, and visitors, are critical. An additional dose of COVID-19 vaccine might be considered for nursing home and long-term care facility residents to optimize a protective immune response.

引用

页码：1163 / 1166

页数：4

共 8 条

[1] Bagchi S, 2021, MMWR-MORBID MORTAL W, V70, P52, DOI 10.15585/mmwr.mm7002e2
[2] Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks - Connecticut, December 2020-February 2021
Britton, Amadea
Slifka, Kara M. Jacobs
Edens, Chris
Nanduri, Srinivas Acharya
Bart, Stephen M.
Shang, Nong
Harizaj, Adora
Armstrong, Jillian
Xu, Kerui
Ehrlich, Hanna Y.
Soda, Elizabeth
Derado, Gordana
Verani, Jennifer R.
Schrag, Stephanie J.
Jernigan, John A.
Leung, Vivian H.
Parikh, Sunil
[J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (11): : 396 - 401
[3] The Advisory Committee on Immunization Practices' Updated Interim Recommendation for Allocation of COVID-19 Vaccine - United States, December 2020
Dooling, Kathleen
Marin, Mona
Wallace, Megan
McClung, Nancy
Chamberland, Mary
Lee, Grace M.
Talbot, H. Keipp
Romero, Jose R.
Bell, Beth P.
Oliver, Sara E.
[J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 69 (51-52): : 1657 - 1660
[4] Emborg H-D, VACCINE EFFECTIVENES, DOI [10.1101/2021.05.27.21257583v1, DOI 10.1101/2021.05.27.21257583V1]
[5] First-Dose COVID-19 Vaccination Coverage Among Skilled Nursing Facility Residents and Staff
Gharpure, Radhika
Patel, Anita
Link-Gelles, Ruth
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (16): : 1670 - 1671
[6] Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021
Mazagatos, Clara
Monge, Susana
Olmedo, Carmen
Vega, Lorena
Gallego, Pilar
Martin-Merino, Elisa
Jose Sierra, Maria
Limia, Aurora
Larrauri, Amparo
[J]. EUROSURVEILLANCE, 2021, 26 (24) : 1 - 6
[7] Monge S, EMERG INFECT DIS, P2021
[8] Puranik A, 2021, MEDRXIV PREPRINT SER, V2021

← 1 →